Terminal Illness Clinical Trial
Official title:
The Effect of Using a Fan With Aromatherapy in Breathlessness Patient in Terminally Illness: a Randomized Control Trial
Difficulty breathing is a very devastating symptom, often seen in terminal patients. Accompanied by physical, psychological, emotional, and social limitations, Not to mention the ambiguity in the occurrence of dyspnea symptoms and the difficulty in obtaining satisfactory quality of symptom care. The purpose of this study is to confirm the use of non-drug interventions in clinical situations, such as fans and aromatherapy to alleviate the complications of end-stage patients. The effectiveness of the symptoms of dyspnea.
Difficulty breathing is a very devastating symptom, often seen in terminal patients. Accompanied by physical, psychological, emotional, and social limitations, Not to mention the ambiguity in the occurrence of dyspnea symptoms and the difficulty in obtaining satisfactory quality of symptom care. The purpose of this study is to confirm the use of non-drug interventions in clinical situations, such as fans and aromatherapy to alleviate the complications of end-stage patients. The effectiveness of the symptoms of dyspnea. Inclusion criteria 1. Over 20 years old. 2. It is determined by the physician to meet the final diagnosis conditions. 3. Symptoms of dyspnea. 4. The daily physical status of patients is assessed using the East Coast Cancer Clinical Research Cooperative Organization Assessment Scale (Eastern Cooperative Oncology Group, ECOG) ≧ 2 points. 5. Able to communicate in Mandarin or Taiwanese or written conversation. 6. Unconscious disorder. 7. After explaining and explaining, agree to participate in this research and sign the consent form. Exclusion criteria 1. Receive treatment for facial trigeminal nerve damage. 2. Abnormal sense of smell. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04078815 -
End-of-life Practices in 2019 vs. 2014
|
||
| Recruiting |
NCT04750395 -
Comparing Haloperidol and Olanzapine in Treating Terminal Delirium
|
Phase 2 | |
| Recruiting |
NCT06108375 -
Differences in Acceptability of Music Therapy Sessions Played Live Compared to a Recording Thereof
|
N/A | |
| Completed |
NCT04030910 -
'LIFEView' Audiovisual Technology: Virtual Travel to Support Wellbeing and Quality of Life at the End of Life
|
N/A | |
| Completed |
NCT04568629 -
ADJUST: A Study on MDT Prognostication
|
N/A | |
| Completed |
NCT03520270 -
Prevalence of Potentially Inappropriate Treatments
|
||
| Recruiting |
NCT04257227 -
Transcranial Magnetic Stimulation for Psychological Distress in Patients With Advanced Illness
|
N/A | |
| Completed |
NCT04678310 -
iLIVE Volunteer Study
|
||
| Completed |
NCT04456647 -
Parenteral Nutrition Therapy in Patients With Incurable Cancer
|
||
| Completed |
NCT02362295 -
Prospective National Survey of the Palliative Situation Among Inmates in French Prisons
|
N/A | |
| Terminated |
NCT03886753 -
Pharmacokinetic (PK) and Pharmacodynamics (PD) Study of Ilera Specific Products
|
||
| Active, not recruiting |
NCT04950608 -
Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice Care
|
Phase 2 | |
| Completed |
NCT03336489 -
Evaluation of the Organization of Continuity of Care for Home Hospice Patients by Four Parisian Health Networks
|
||
| Completed |
NCT03392857 -
End Of Life in the Critically Ill patiEnt
|
||
| Completed |
NCT03697213 -
The Surprise Study
|
||
| Completed |
NCT01367613 -
Open-Label Treatment Extension of Protocol MNTX 302
|
Phase 3 | |
| Recruiting |
NCT04612738 -
Project Talk Trial: Engaging Underserved Communities in End-of-life Conversations
|
N/A | |
| Completed |
NCT02067572 -
A Randomized Controlled Trial Evaluating the Effectiveness of a Salvia-based Mouthwash in Palliative Care
|
N/A | |
| Withdrawn |
NCT03041571 -
Impact of Early Implementation of Narrative Medicine Techniques on Patient Centered Attitudes of Medical Students
|
||
| Terminated |
NCT03616639 -
Neurotoxic Adverse Effects of Morphine and Oxycodone for Pain in Terminal Patients With Diminished Renal Function
|
Phase 4 |